CD105 (endoglin) expression as a prognostic marker of angiogenesis in squamous cell cervical cancer treated with radical radiotherapy

Metcalfe E., Arık D., Öge T., Etiz D., Yalçın Ö. T., Kabukcuoglu S., ...Daha Fazla

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.14, ss.1373-1378, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 14
  • Basım Tarihi: 2018
  • Doi Numarası: 10.4103/0973-1482.203602
  • Dergi Adı: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1373-1378
  • Anahtar Kelimeler: Angiogenesis, CD105/endoglin, cervical cancer, chemoradiotherapy, radiotherapy, TUMOR ANGIOGENESIS, MICROVESSEL DENSITY, CHEMOTHERAPY, BIOMARKERS
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Introduction: Increased levels of endoglin may represent a new reagent of active neovascularization and angiogenesis process in various cancer types. The prognostic value of tumor CD105 (endoglin) expression in cervical squamous cell cancer (CSCC) patients treated with radical radiotherapy (RT) +/- chemotherapy was investigated.